Madrid, Noviembre de 2012.- La Sociedad Española de Neurorradiología ha concedido unánimemente el “Premio a la profesión en Radiología" al neurorradiólogo del hospital Gregorio Marañón, Francisco Villoria Medina, en reconocimiento a la extraordinaria labor profesional que desempeña en este centro sanitario de la Comunidad de Madrid, y que le ha sido entregado en un acto conmemorativo del día internacional de la Radiología.
A new study has found that diffusion tensor imaging may be able to predict which patients who have experienced concussions will improve. The results, presented at the annual meeting of the Radiological Society of North America (RSNA), suggest that, in some patients, the brain may change to compensate for the damage caused by the injury.
Marc Ribo, Unitat d’lctus, Hospital Vall d’Hebron, Barcelona, Spain, and colleagues, in a study published ahead-of-print in the Journal of Neurointerventional Surgery, said that difficult catheter access to the carotid artery during endovascular treatment of stroke patients is common and is associated with worse clinical outcomes.
Alejandro M Spiotta, Department of Neurosurgery, Medical University South Carolina, Charleston, USA, reported his team’s experience with the new balloon-stent technique for intracranial aneurysm treatment using the Scepter C balloon catheter and the LVIS, a low-profile visualised intraluminal stent.
By John R Adler Jr and Robert Dodd. Intramedullary spinal cord AVMs are rare lesions with an estimated incidence of only 0.02/100,000 person-years. Having a proclivity to affect young adults, this rare condition is associated with progressive spinal cord ischaemia and a significant risk of haemorrhage, often resulting in paralysis. Despite advances in microsurgery and intravascular embolization, many AVMs are not amenable to curative therapies because of their intra-parenchymal spinal cord location and/or a common anterior spinal artery blood supply. Even in very experienced hands, microsurgery and intravascular embolization—both established therapies—are associated with a considerable risk of complications. As a result, there are no good treatment options for many, if not most, intramedullary spinal cord AVMs.
Data from the large SAPPHIRE WW Worldwide registry suggest that age, symptomatic status, and physiological entry criteria represent high risk features for carotid artery stenting. Christopher Metzger, Wellmont CVA Heart Institute, Kingsport, USA, national co-principal investigator of the registry, presented periprocedural results of 15,000 carotid artery stenting patients at the TCT conference in Miami.
Stryker announced the global commercial launch of the new Trevo ProVue Retriever. According to a company release, this is the first clot removal device fully visible during the procedure for precise positioning within the clot and optimised clot retrieval in patients experiencing acute ischaemic stroke. Previous technology only provided visibility to the edges of the device.
KALAMAZOO, Mich., Nov. 8, 2012 /PRNewswire/ -- Stryker announced today the global commercial launch of the new Trevo® ProVue Retriever. The Trevo ProVue Retriever is the first clot removal device fully visible during the procedure for precise positioning within the clot and optimized clot retrieval in patients experiencing acute ischemic stroke. Previous technology only provided visibility to the edges of the device.
Asahi Intecc has announced the launch of Asahi Chikai and Asahi Chikai10 neurovascular guidewires in the USA and Europe and will begin promotion at the Live Interventional Neuroradiology Conference (LINC, Houston, USA, 11–13 December).
OREM, Utah, Nov. 1, 2012 /PRNewswire/ -- sBioMed, an emerging leader in infection control, announced today that Stephen P. MacMillan, former Chairman and CEO of Stryker, has joined the company as Chief Executive Officer and become an owner of the company.
Phenox GmbH announced that the p64 Flow Modulation Device has received the CE mark approval for commercialisation within the European Union. Hermann Monstadt, managing director at phenox, Bochum, Germany, said: “This approval supports our strategy of moving neurovascular therapies forward through technological innovation and adds to our product portfolio in a way that supports physicians with better tools and as a result provide additional benefits to patients with complex brain aneurysms.”
Just one month ago, Kevin Lobo took over the top spot at medical device maker Stryker Corp. (NYSE:SYK) On Monday, he explained the $8.5 billion corporation s innovation strategy moving forward in his first public appearance as CEO at Cleveland Clinic s Medical Innovation Summit.
Madrid, Octubre de 2012.- Un equipo multidisciplinar del Clínico San Carlos integrado por neurocirujanos, neurorradiólogos vasculares intervencionistas y neurólogos han tratado con éxito a 13 pacientes con malformaciones vasculares cerebrales de alta complejidad, según queda patente en los trabajos publicados en dos revistas internacionales científicias: British Journal of Neurosurgery y Acta Neurologica Scandinavica.
Acandis has announced CE mark approval for its Acandis Aperio 1.9F Thrombectomy System, a next-generation self-expanding blood clot retrieval system used to treat patients with ischaemic strokes.
A study, led by Willem van Zwam, Maastricht University Medical Centre, Maastricht, The Netherlands, published ahead of print in the eJournal of the European Society of Minimally Invasive Neurological Therapy (EJMINT) investigated whether contrast enhanced magnetic resonance angiography (CEMRA) could be an alternative in diagnosing intracranial aneurysms in patients presenting with subarachnoid haemorrhage compared with computed tomographic angiography (CTA).
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos